Patents by Inventor Mona Landin-Olsson

Mona Landin-Olsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5547847
    Abstract: Methods for predicting the clinical course of diabetes in patients diagnosed as having NIDDM are provided. Patients having NIDDM are tested for the presence of autoantibodies to human islet cell glutamic acid decarboxylase. Based on the presence or absence of autoantibodies, the patients are classified as to the predicted course of the disease. These methods can be used to predict the development of IDDM and to guide therapeutic intervention.
    Type: Grant
    Filed: September 7, 1993
    Date of Patent: August 20, 1996
    Assignee: University of Washington
    Inventors: William Hagopian, Ake Lernmark, Allan E. Karlsen, Mona Landin-Olsson